Evogene (EVGN) Reports Q3 Loss of $0.16/Share

Evogene (NASDAQ: EVGN) reported Q3 EPS of ($0.16), versus ($0.19) reported last year. Revenue for the quarter came in at $97 thousand, versus $367 thousand reported last year.

For earnings history and earnings-related data on Evogene (EVGN) click here.

You May Also Be Interested In

• Tesla to launch Cybercab in Austin this month - report
• Is Treasury selloff a major issue for stock market bulls?
• Smith-Midland Corporation (SMID) Tops Q2 EPS by 26c